BeStock  

Encompass Health EHC

US equityMarket cap rank #1213Medical Care Facilities
$133.65 +$1.37 (+1.04%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $133.65 0.00%
Open$133.60
Prev close$132.28
Day range$132.55 – $134.84
Volume911.9K
Market cap$13.11B
P/E (TTM)20.9
Dividend yield0.58%

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

EHC at a glance

Encompass Health stock (EHC) sits at $133.65, up 1.04% today. The business is worth $13.11B in the market, good for #1213 of 3753 on our coverage list.

The 52-week range is $92.25 to $143.90. Today's price is about 80% of the way from the low to the high. Holders are ahead 17.5% over twelve months, and up 10.5% across the last three months.

On the chart it holds above both the 50-day ($128.14) and 200-day ($113.01) moving averages; RSI is 50, and the last 30 sessions moved at roughly 40% annualized volatility.

Revenue for the quarter ended Sep 2026 was $1.61B, up 8.9% from a year earlier, with $203.60M of net profit (a 10.1% margin).

Buyers are paying 20.9 times trailing earnings, about in line with its own five-year average of 20.6. The median for its industry group is 20.4.

8 analysts follow the stock and the average call is "buy". The mean target, $152.50, sits 14.1% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$132.00 / $176.73
Average price today$133.74
Volume911.9KAvg (90d) 975.0K
Turnover$121.96M
Turnover rate0.94%of shares outstanding
Volume ratio1.12vs. recent average pace
Day amplitude1.73%
Market cap$13.11B
Float market cap$12.98B
Shares outstanding97.15M
EPS (TTM)$5.54
P/E (TTM)20.88
P/B4.89
Book value / share$27.33
Earnings yield4.79%
Dividend (TTM)$0.78 / shareYield 0.58%
Net profit (TTM)$543.60M
Net assets$2.68B
30-day volatility39.6%annualized
Avg daily range (ATR)2.79%of price, 14 days
Max drawdown (1y)-19.1%-6.2% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 4 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Income

Higher trailing yield than most of BeStock’s coverage scores higher.

A
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

8 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 91.1 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation46.8
Growth87.4
Profitability86.5
Momentum88.4
Financial health21.8
Analyst view50.2

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$152.50+14.1% vs. current price
Consensus ratingBuy8 analysts covering
Morningstar fair value$131.16Close to fair value

Wall Street’s average 12-month target is $152.50, 14.1% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $131.16, so shares trade 1.9% above that estimate. On earnings multiple, it sits in the 47th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+1.0%
1 week
-5.2%
1 month
+6.1%
3 months
+10.5%
6 months
+27.6%
Year to date
+26.6%
1 year
+17.5%
Day range
$132.55$134.84
52-week range
$92.25$143.90

Technical signals

Full technicals →
Trend readLeaning bearish

3 bullish · 4 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-1.6%Bearish
Price vs 50-day average+4.3%Bullish
Price vs 200-day average+18.3%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)49.9Bearish
MACD (12,26,9)2.62Bearish
Bollinger band position42%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How EHC ranks on BeStock

Market value#1212 of 3734
P/E (cheapest = 1)#1757 of 2917
Dividend yield#2062 of 2245
Closeness to 52-week high#357 of 3724
Dollar volume today#894 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

Set against the peer table: at 20.9x earnings, EHC looks about mid-pack against the market, and trades 2% above the 20.4x median among Medical Care Facilities names. The two comparisons do not always agree.

EHC is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on EHC.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on EHC

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

EHC stock: common questions

What is EHC's latest share price?

$133.65 is the latest print for EHC, a move of +1.04% against yesterday's close of $132.28. Today's low and high so far: $132.55 and $134.84.

How large is Encompass Health by market value?

Equity value comes to $13.11B at the current price. By that measure it is number 1213 of the 3753 names in our coverage.

How is Encompass Health valued against its profits?

Buyers pay 20.9 times the last twelve months of profit (EPS $5.54). Averaged over five years the multiple has been 20.6, and today's level ranks in the 47th percentile of its own history.

How far is EHC from its yearly high?

The year's floor is $92.25 and the ceiling $143.90. Shares are 7.1% away from that ceiling.

Are there dividends on Encompass Health shares?

It does. Payouts over the past twelve months work out to a 0.58% yield; the latest ex-dividend date was October 1, 2026.

What is the analyst view on Encompass Health?

Of 8 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $152.50, with the most cautious at $142.00 and the most optimistic at $165.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on EHC.

Sign in to join the discussion.

Scroll to Top